Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Operating Expenses: 2014-2024

Historic Other Operating Expenses for Soleno Therapeutics (SLNO) over the last 8 years, with Dec 2024 value amounting to $3.2 million.

  • Soleno Therapeutics' Other Operating Expenses rose 298.41% to $1,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $4,251, marking a year-over-year decrease of 99.25%. This contributed to the annual value of $3.2 million for FY2024, which is 19.45% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Other Operating Expenses of $3.2 million as of FY2024, which was up 19.45% from $2.7 million recorded in FY2023.
  • Soleno Therapeutics' 5-year Other Operating Expenses high stood at $3.2 million for FY2024, and its period low was -$712,000 during FY2022.
  • For the 3-year period, Soleno Therapeutics' Other Operating Expenses averaged around $1.7 million, with its median value being $2.7 million (2023).
  • Data for Soleno Therapeutics' Other Operating Expenses shows a peak YoY skyrocketed of 481.18% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Soleno Therapeutics' Other Operating Expenses stood at -$712,000 in 2022, then soared by 481.18% to $2.7 million in 2023, then rose by 19.45% to $3.2 million in 2024.